IP Library Granted Patent US 7,509,156
Granted Patent B2
US 7,509,156 · App. 11/131,707 · Granted Mar 24, 2009

System for managing glucose levels in patients with diabetes or hyperglycemia

Assignee: Clarian Health Partners, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,509,156
App. No.
11/131,707
Granted
Mar 24, 2009
Kind
B2
Abstract

A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.

Claims (10)

1. A system for maintaining a blood glucose level in an individual comprising:

setup means for establishing a desired range of blood glucose levels for said individual;

measuring means for determining a blood glucose level for said individual;

calculating means responsive to said blood glucose level for determining a proper glucose dosage amount for said individual when said blood glucose level is below said desired range and for determining a proper insulin dosage amount for said individual when said blood glucose level is above said desired range;

delivery means for administering at least one of said glucose dosage amount or said insulin dosage amount to said individual;

evaluation means responsive to said blood glucose level for determining a time interval for said individual after which said individual's blood glucose level is to be re-measured;

timing means for generating a signal when said time interval has elapsed; and

estimating means responsive to said calculated glucose dosage amount or said calculated insulin dosage amount, and to at least one criteria associated with said individual, for estimating the accuracy of said calculated dosage amount.

2. The system described in claim 1 , further comprising notification means for generating an alert signal when said estimated accuracy is below a predetermined level.

3. The system described in claim 2 , wherein said alert signal is auditory.

Assignments (2)
CHANGE OF NAME Recorded Nov 8, 2011
From: CLARIAN HEALTH PARTNERS, INC.
To: INDIANA UNIVERSITY HEALTH, INC.
Reel/Frame 027196/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2006
From: FLANDERS, DR. SAMUEL J.
To: CLARIAN HEALTH PARTNERS, INC.
Reel/Frame 018012/0040 →
Continuity (1)
Related Publication 20060264895A1 · Nov 23, 2006